Efficacy-Safety-Immunogenicity Study of CBT124&EU-sourced Avastin® in Stage 4 NSCLC

计划入组 200 人 · 首次发布于 2016 年 8 月 25 日

A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC

计划入组 70 人 · 首次发布于 2024 年 2 月 7 日

Thoracic Radiotherapy for Patients With Metastatic (Stage IV) Non-Small Cell Lung Cancer at High Risk of Symptomatic Progression Within the Thorax

计划入组 48 人 · 首次发布于 2024 年 2 月 16 日

squamous NSCLC vaccine

NSCLC (Antibody Therapeutics)

NANT Non-small Cell Lung Cancer Vaccine

Xi'an No.4 Hospital

China

Guiyang No.4 People's Hospital

China

Huai'an No.4 People's Hospital

China

Targeted Therapies Transform Stage 4 Lung Cancer from Death Sentence to Chronic Condition

Kiromic BioPharma Expands Deltacel-01 Trial for NSCLC to University of Arizona Cancer Center

Eikon Therapeutics to Present Phase 2 Data on Novel TLR7/8 Co-Agonist EIK1001 for Advanced NSCLC at ESMO 2025